ANNX
Price
$2.15
Change
-$0.00 (-0.00%)
Updated
Aug 26 closing price
Capitalization
236.26M
77 days until earnings call
NRIX
Price
$9.53
Change
-$0.14 (-1.45%)
Updated
Aug 26 closing price
Capitalization
728.56M
43 days until earnings call
Interact to see
Advertisement

ANNX vs NRIX

Header iconANNX vs NRIX Comparison
Open Charts ANNX vs NRIXBanner chart's image
Annexon
Price$2.15
Change-$0.00 (-0.00%)
Volume$1.05M
Capitalization236.26M
Nurix Therapeutics
Price$9.53
Change-$0.14 (-1.45%)
Volume$620.55K
Capitalization728.56M
ANNX vs NRIX Comparison Chart in %
Loading...
ANNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NRIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ANNX vs. NRIX commentary
Aug 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANNX is a Buy and NRIX is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 27, 2025
Stock price -- (ANNX: $2.15 vs. NRIX: $9.53)
Brand notoriety: ANNX and NRIX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ANNX: 79% vs. NRIX: 76%
Market capitalization -- ANNX: $236.26M vs. NRIX: $728.56M
ANNX [@Biotechnology] is valued at $236.26M. NRIX’s [@Biotechnology] market capitalization is $728.56M. The market cap for tickers in the [@Biotechnology] industry ranges from $99.27B to $0. The average market capitalization across the [@Biotechnology] industry is $1.85B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ANNX’s FA Score shows that 1 FA rating(s) are green whileNRIX’s FA Score has 1 green FA rating(s).

  • ANNX’s FA Score: 1 green, 4 red.
  • NRIX’s FA Score: 1 green, 4 red.
According to our system of comparison, both ANNX and NRIX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ANNX’s TA Score shows that 3 TA indicator(s) are bullish while NRIX’s TA Score has 5 bullish TA indicator(s).

  • ANNX’s TA Score: 3 bullish, 5 bearish.
  • NRIX’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, NRIX is a better buy in the short-term than ANNX.

Price Growth

ANNX (@Biotechnology) experienced а -1.83% price change this week, while NRIX (@Biotechnology) price change was -3.15% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.28%. For the same industry, the average monthly price growth was +23.07%, and the average quarterly price growth was +32.06%.

Reported Earning Dates

ANNX is expected to report earnings on Nov 12, 2025.

NRIX is expected to report earnings on Oct 09, 2025.

Industries' Descriptions

@Biotechnology (+4.28% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NRIX($729M) has a higher market cap than ANNX($236M). NRIX YTD gains are higher at: -49.416 vs. ANNX (-58.090). ANNX has higher annual earnings (EBITDA): -198.44M vs. NRIX (-212.78M). NRIX has more cash in the bank: 486M vs. ANNX (227M). ANNX has less debt than NRIX: ANNX (27.6M) vs NRIX (51.9M). NRIX has higher revenues than ANNX: NRIX (88.4M) vs ANNX (0).
ANNXNRIXANNX / NRIX
Capitalization236M729M32%
EBITDA-198.44M-212.78M93%
Gain YTD-58.090-49.416118%
P/E RatioN/AN/A-
Revenue088.4M-
Total Cash227M486M47%
Total Debt27.6M51.9M53%
TECHNICAL ANALYSIS
Technical Analysis
ANNXNRIX
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
79%
Momentum
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
84%
MACD
ODDS (%)
Bearish Trend 2 days ago
84%
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 5 days ago
84%
Bullish Trend 5 days ago
82%
Declines
ODDS (%)
Bearish Trend 7 days ago
90%
Bearish Trend 7 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
70%
Bullish Trend 2 days ago
81%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
ANNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NRIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JEPCX14.140.01
+0.07%
JPMorgan Equity Premium Income C
PIUCX23.78N/A
N/A
Federated Hermes International Equity C
RYMQX24.69N/A
N/A
Guggenheim Multi-Hedge Strategies A
SJCIX32.46N/A
N/A
Steward Large Cap Core I
IUEFX29.31-0.02
-0.07%
JPMorgan International Focus R5

ANNX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ANNX has been loosely correlated with IDYA. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if ANNX jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANNX
1D Price
Change %
ANNX100%
N/A
IDYA - ANNX
49%
Loosely correlated
+0.61%
OCUL - ANNX
47%
Loosely correlated
+3.79%
NRIX - ANNX
46%
Loosely correlated
-1.45%
SYRE - ANNX
46%
Loosely correlated
+2.90%
AURA - ANNX
45%
Loosely correlated
-0.31%
More

NRIX and

Correlation & Price change

A.I.dvisor indicates that over the last year, NRIX has been closely correlated with KYMR. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if NRIX jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NRIX
1D Price
Change %
NRIX100%
-1.45%
KYMR - NRIX
68%
Closely correlated
+4.90%
IDYA - NRIX
61%
Loosely correlated
+0.61%
DNLI - NRIX
58%
Loosely correlated
-0.13%
CRNX - NRIX
56%
Loosely correlated
+2.79%
BEAM - NRIX
55%
Loosely correlated
+1.22%
More